Thanks Andy. Let's begin with a review of our Q1 performance on Slide #5. During the quarter, consolidated revenues decreased 3% on a GAAP basis and was down 2% in constant currency. Revenue performance was driven by 6% growth at ADI which was more than offset by revenue decreasing 14% at Products and Solutions. The COVID-19 pandemic began to negatively impact sales performance at both our segments towards the end of the quarter. Consolidated adjusted EBITDA was down 22% in the quarter primarily because of lower sales volume and weaker mix at Products and Solutions due in part to COVID-19. As disclosed in the earnings release footnote, we have modified our definition of adjusted EBITDA. Current and prior quarters adjusted EBITDA now excludes both expense and cash payments associated with the Honeywell reimbursement agreement. These items are not related to the underlying Resideo operating performance and future cash payments will not be as consistent as they were in 2019. In our original guidance for 2020, we assumed $35 million cash payment per quarter for total $140 million cash payments for the year which was deducted in arriving at the previous definition of adjusted EBITDA. We also reclassified research and development costs from cost of goods sold to SG&A in the income statement. This change will be reflected in all years presented. We believe this line item reclassifications better reflects the underlying costs and industry practice. During our Q4 earning call, we provided some context of expected Q1 2020 revenue growth and adjusted EBITDA growth performance. As we expected Q1 financial results as compared to the previous year to be anomalous to our full year 2020 guidance. Our Q1 2020 performance was trending slightly better in the Q1 expectations prior to the impact of COVID-19. Our actual Q1 revenues finished down low single digits consistent with what we conveyed on the Q4 earnings call, while adjusted EBITDA finished slightly better in those expectations due primarily to better sales mix at P&S. The COVID-19 pandemic has had a negative impact on our revenues which started towards the end of the quarter and continues through today. For April, total Resideo sales were down 25% with ADI down 21% and P&S down 30%. These results include the impact of COVID-19 and other current and prior year revenue components. As the economy opens up, we expect revenue to improve, but we cannot anticipate how the crisis will evolve. We have conducted surveys of homeowners and preliminary results were flat as the majority of our customers anticipate completing their planned home projects. We think the majority of our recently lost revenue has not disappeared but just moved further into the latter part of this year. It's worth noting, we are able to partially mitigate the COVID-19 impact through targeted cost reductions taken across all of our business segment. These measures include salary reductions, travel restrictions and implementation of f furlough program. We also restricted new hiring activity and eliminated the service fees for our board of directors for the first quarter. Due to timing, these actions only had a partial impact on Q1 resutls. Moving forward, we will continue to actively manage our business and we will evaluate additional measures we can take to align our cost structure with the impact of COVID-19. Now moving to the segment discussion. At ADI the app revenue increased 6% in the quarter. On a constant currency basis revenue finished up 7%. Revenue performance at ADI in the period was solid especially considering we began to see the negative impact of COVID-19 in March. The Herman AB [ph] acquisition added about 1% to revenue growth for the quarter. ADI EBITDA was flat the prior year as well as revenue increase was offset by weaker product line and customer mix, ongoing investments in our e-commerce platform and commercial headcount in branch expansions to support future revenue. On the e-commerce side, we see big opportunities to expand the channel ADI. With increased telesales staff and improved website and additional e-commercial software investments we believe this channels provides a great opportunity for each customers. Turning now to Products & Solutions, where revenues were down 14% on a GAAP basis and 13% in constant currency. The revenue decline in Q1 is driven by lower volumes across security, comfort and RTS. The overall volume decline at P&S was driven in part by the overlap of a particularly strong first quarter of 2019. Products and Solutions adjusted EBITDA finished down 35% compared to Q1 of last year. The decline was driven by lower volumes this quarter as well as unfavorable product and channel mix. Mix shift to lower margin connected thermostats, our lower margin growth security products and lower trade channel sales in our RTS business, all impacted this mix. Turning now to Slide #6, which shows the key variance drivers of our total revenue and adjusted EBITDA performance in Q1. Total company revenue was down 3% as reported and 2% on a constant currency basis. On a GAAP basis ADI revenues were up $44 million, while revenue P&S were down $72 million compared to Q1 of last year. Overall currency impact in Q1 was a negative $9 million. Adjusted EBITDA in Q1 was $99 million compared to $127 million in Q1 of last year. Both years excluded any expense or cash payment pursuant to the Honeywell reimbursement agreement. By far the biggest negative driver of the year-over-year decline was the combination of volume down $32 million and the P&S revenue reduction and price mix down $17 million. As previously discussed, we experienced negative mix shift with each business segment. In addition, as ADI grows faster than Products and Solutions, total Resideo experiences lower profit margins as the ADI business segment is a lower margin business. We have $16 million adjusted EBITDA benefit from our transformation programs and another $8 million related to the cost reduction initiatives implemented during COVID-19. These transformational cost reductions reflect savings from previous year's headcount reduction initiative and initial savings from our financial and operational review. The COVID-19 cost actions were driven by reduced headcount costs and salary reductions, [indiscernible] and other corporate cost reduction efforts. We expect the COVID-19 reductions to be temporary. As we return to normal compensation methodologies the impact of the crisis our business subsides. Lastly, there was about $3 million of incremental costs reflected on this slide as other due primarily to engineering and sales headcount investments made in 2019. Regarding our full year outlook, we stated in our COVID-19 update release, given the rapidly evolving operating conditions and market uncertainty, caused by COVID-19 we withdrew our full year 2020 outlook. Like many others we are unable to accurately estimate the impact of COVID-19 on our performance and financial results at this time. We will continue to closely monitor the impact of COVID-19 on our business and markets and provide an update as appropriate. Now I'll take a few minutes to discuss our liquidity and capital structure on Slide #7. In terms of cash and liquidity, our cash balance at March 31, is $238 million. This includes the drawdown funds available under our $350 million revolving credit facility which we did as a conservative measure to enhance our liquidity position. We continue to focus on reducing our net working capital investment and reduce planned capital spending. On the working capital front, we are improving processes across receivables, payables and inventories which should benefit the company after the COVID-19 crisis passed. In April, we announced that Resideo and Honeywell have agreed to defer approximately $42 million in payments due to Honeywell in Q2 until July 30. This includes $35 million in payments under the Honeywell reimbursement agreement and $7 million in payments in connection with our trademark license agreement. We agreed to this arrangement with Honeywell as part of the ongoing dialogue regarding our relationship which we expect to continue in Q2. Turning to capital structure, our next significant debt maturity is due in 2020. As of March 31 we were in compliance with our debt covenants. In addition to the deferred payments to Honeywell, we also reached an agreement to incorporate the leverage ratio included in our credit agreement amendment on December 2019 into the Honeywell reimbursement agreement. Moving forward, we will continue to focus on strengthening our liquidity and cash position as we navigate the challenging operating environment caused by the COVID-19 pandemic. I'll now turn the call back over to Andy for his summary remarks. Andy?